BMT CTN Protocol 1501: A randomized, Phase II Multicente

Project: Research project

Description

BMT CTN Protocol 1501: A randomized, Phase II Multicenter, Open Label Study Evaluating Sirolimus and Prednisone in Patients with Minnesota Standard Risk, Ann Arbor 1/2 Confirmed Acute Graft-Versus Host Disease
StatusFinished
Effective start/end date11/8/168/31/19

Funding

  • National Marrow Donor Program

Fingerprint

Graft vs Host Disease
Sirolimus
Prednisone
trans-crotonin